MPS I DRUG MARKET: KEY TRENDS AND LONG-TERM OUTLOOK

Mucopolysaccharidosis Type I (MPS I) is a rare inherited metabolic disorder that affects the body's ability to break down glycosaminoglycans (GAGs), leading to their accumulation in various tissues and organs. This accumulation results in progressive organ damage and dysfunction. Symptoms of MPS I can vary, including developmental delays, organ enl